List of publications on a keyword: «synthetic cannabinoids withdrawal syndrome»


Медицина

Publication date: 10.04.2017
Evaluate the material Average score: 4 (Всего: 1)
Antsyborov Andrey Viktorovich , врач психиатр-нарколог
Medical Center "Mobilnaya medicina" , Ростовская обл
Mrykhin Vladimir Valerievich , candidate of medical sciences , доцент
FSFEI of HE “Rostov State Medical University” of Russia Ministry of Health , Ростовская обл

«Synthetic cannabinoids: new matrix addiction»

Download an article

The majority of synthetic cannabinoids (SC), belongs to the group of so-called designer drugs distributed through illegal online shopping. The first reports of this group of psychoactive substances appeared in the 70s of the last century. Today, according to various estimates, there are over 160 varieties of synthetic cannabinoids, and this figure is increasing annually due to the synthesis of new substances in the group. This group of substances is designed to «copy» the psychoactive effects of cannabis. Initially, these substances were created solely for research purposes, to study the endocannabinoid system of the person. Natural THC is a partial agonist of cannabinoid receptors. Synthetic cannabinoids are full agonists CB1R and CB2R types of cannabinoid receptors. Most countries in the world, including Russia, at the legislative level have taken restrictive measures for preventing the spread of this group of substances. In order to circumvent the legislative measures, the producers of synthetic cannabinoids regularly changing the chemical formula. Each year, an increasing number of emergency hospital admissions associated with the use of synthetic cannabinoids in the peer-reviewed literature describes the deaths directly attributable to medical complications after taking synthetic cannabinoids. Numerous studies have proven the possibility of developing psychological dependence due to the use of synthetic cannabinoids. The proposed review of the literature is presented for the purpose of organizing data in the field of synthetic cannabinoids.